Abstract:Detailed structural characterization of small molecule metabolites is desirable during all stages of drug development, and often relies on the synthesis of metabolite standards. However, introducing structural changes into already complex, highly functionalized small molecules both regio- and stereo-selectively can be challenging using purely chemical approaches, introducing delays into the drug pipeline. An alternative is to use the cytochrome P450 enzymes (P450s) that produce the metabolites in vivo, taking advantage of the enzyme's inherently chiral active site to achieve regio- and stereoselectivity. Importantly, biotransformations are more sustainable: they proceed under mild conditions and avoid environmentally damaging solvents and transition metal catalysts. Recombinant enzymes avoid the need to use animal liver microsomes. However, native enzymes must be stabilized to work for extended periods or at elevated temperatures, and stabilizing mutations can alter catalytic activity. Here we assessed a set of novel, thermostable P450s in bacterial membranes, a format analogous to liver microsomes, for their ability to metabolize drugs through various pathways and compared them to human liver microsomes. Collectively, the thermostable P450s could replicate the metabolic pathways seen with human liver microsomes, including bioactivation to protein-reactive intermediates. Novel metabolites were found, suggesting the possibility of obtaining metabolites not produced by human or rodent liver microsomes. Importantly, no alteration in assay conditions from standard protocols for microsomal incubations was necessary. Thus, such bacterial membranes represent an analogous metabolite generation system to liver microsomes in terms of metabolites produced and ease of use, but which provides access to more diversity of metabolite structures. SIGNIFICANCE STATEMENT In drug development it is often chemically challenging, to synthesize authentic metabolites of drug candidates for structural identification and evaluation of activity and safety. Biosynthesis using microsomes or recombinant human enzymes is confounded by the instability of the enzymes. Here we show that thermostable ancestral cytochrome P450 enzymes derived from P450 families responsible for human drug metabolism offer advantages over the native human forms in being more robust and over microbial enzymes in faithfully reflecting human drug metabolism.

Biotechnological Synthesis of Drug Metabolites Using Human Cytochrome P450 2d6 Heterologously Expressed in Fission Yeast Exemplified for the Designer Drug Metabolite 4 '-Hydroxymethyl-alpha-pyrrolidinobutyrophenone

Biotechnological Synthesis of the Designer Drug Metabolite 4'-Hydroxymethyl-alpha-pyrrolidinohexanophenone in Fission Yeast Heterologously Expressing Human Cytochrome P450 2D6--a Versatile Alternative to Multistep Chemical Synthesis.

Biotechnological synthesis of drug metabolites using P 450-expressing fission yeast – new perspectives in metabolism studies for 4 ’ methyl-a-pyrrolidinobutyrophenone

Use of fission yeast heterologously expressing human cytochrome P450 2B6 in biotechnological synthesis of the designer drug metabolite N-(1-phenylcyclohexyl)-2-hydroxyethanamine

Biotechnological Synthesis of Drug Metabolites Using Human Cytochrome P450 Isozymes Heterologously Expressed in Fission Yeast

Biotechnological Synthesis Of Drug Metabolites Using Human Cytochrome P450 Isozymnes Heterologously Expressed In Fission Yeast

Precision Biotransformation of Emerging Pollutants by Human Cytochrome P450 Using Computational–Experimental Synergy: A Case Study of Tris(1,3-dichloro-2-propyl) Phosphate

Isolation and Purification of the Desig- ner Drug Metabolite O-Desethyl-N- (1-phenylcyclohexyl)-3-ethoxy- propanamine (O-Desethyl-PCEPA) Biotechnologically Synthesized using Fission Yeast Expressing CYP2D6

Convenient Gram-Scale Metabolite Synthesis by Engineered Fission Yeast Strains Expressing Functional Human P450 Systems

MICROSYNTHESIS OF A NOVEL HERBICIDE, PROPYL 4-[ 2-[ (4,6-DIMETHOXY-2-PYRIMIDINYL) OXY] BENZYLAMINO] BENZOATE

Experimental and Computational Studies on the Biotransformation of Pseudopyronines with Human Cytochrome P450 CYP4F2

Selective P450<sub>BM3</sub> Hydroxylation of Cyclobutylamine and Bicyclo[1.1.1]pentylamine Derivatives: Underpinning Synthetic Chemistry for Drug Discovery

In Silico and Chromatographic Methods for Analysis of Biotransformation of Prospective Neuroprotective Pyrrole-Based Hydrazone in Isolated Rat Hepatocytes

Engineering of Human CYP3A Enzymes by Combination of Activating Polymorphic Variants

Biocatalysis using Thermostable Cytochrome P450 Enzymes in Bacterial Membranes - Comparison of Metabolic Pathways with Human Liver Microsomes and Recombinant Human Enzymes

Challenges of Steroid Biotransformation with Human Cytochrome P450 Monooxygenase CYP21 Using Resting Cells of Recombinant Schizosaccharomyces Pombe.

Synthesis of mono Cytochrome P450 in a modified CHO-CPR cell-free protein production platform

Promiscuity of Omphalotin A Biosynthetic Enzymes Allows de novo Production of Non-Natural Multiply Backbone N-Methylated Peptide Macrocycles in Yeast

Late Microaerobic Growth for Efficient Production of Human Cytochrome P450 3A4 in E. coli

Metabolic characterization of 25X-NBOH and 25X-NBOMe phenethylamines based on UHPLC-Q-Exactive Orbitrap MS in human liver microsomes

A fungal CYP from Beauveria bassiana with promiscuous steroid hydroxylation capabilities